REPEAT/Varian Medical Systems Management to Present at Goldman Sachs' 22nd Annual Healthcare Conference Today.Business Editors/Health & Medical Writers REPEATING...due to garble gar·ble tr.v. gar·bled, gar·bling, gar·bles 1. To mix up or distort to such an extent as to make misleading or incomprehensible: She garbled all the historical facts. 2. PALO ALTO, Calif.--(BW HealthWire)--June 13, 2001 The management of Varian Medical Systems Varian Medical Systems (NYSE: VAR) is engaged in the design and manufacture of advanced equipment and software solutions for treating cancer with radiation, as well as x-ray tubes for original equipment manufacturers, replacement x-ray tubes and flat-panel digital subsystems is scheduled to make a presentation at 9 a.m. PST PST Paroxysmal supraventricular tachycardia, see there today at the Goldman Sachs 22nd Annual Healthcare Conference in Laguna Niguel, Calif. Varian Medical Systems President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. Richard M. Levy and Chief Financial Officer Elisha W. Finney will present on cancer treatment and X-ray imaging technology, the company's market position, and the outlook for the year, which is unchanged from what was reported at the end of the second quarter of the company's fiscal year. The webcast will be carried live and then replayed on the Goldman Sachs and Varian Medical Systems' websites. The conference presentation can be accessed via the investor relations Investor relations The process by which the corporation communicates with its investors. page of the company website at www.varian.com. At the prompt, please use username: conference/conf8 and password: goldman8 to access the site. The "Live Audio Webcast" link for Varian Medical Systems will be listed in the 9:00 a.m. timeslot. The webcast will be available for replays via the investor relations page of the Varian website. This press release contains certain forward looking statements within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995 which provides a "safe harbor" for these types of statements. These forward-looking statements are subject to risks and uncertainties that could cause the actual results of Varian Medical Systems, Inc. to differ materially from management's current expectations. These risks and uncertainties include, without limitation, product demand and market acceptance risks; new product development and commercialization; and other risks detailed in Varian Medical Systems, Inc. filings with the Securities and Exchange Commission. Varian Medical Systems, Inc. assumes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise. Varian Medical Systems, Inc., (NYSE NYSE See: New York Stock Exchange :VAR) of Palo Alto, California “Palo Alto” redirects here. For other uses, see Palo Alto (disambiguation). Palo Alto (IPA: /ˌpæloʊˈʔæltoʊ/, from Spanish: palo: "stick" and alto: "high", i.e. is the world's leading manufacturer of integrated cancer therapy systems, which are treating thousands of patients per day. The company is also a premier supplier of X-ray tubes and flat-panel digital subsystems for imaging in medical, scientific, and industrial applications. Varian Medical Systems employs approximately 2,300 people who are located at manufacturing sites in North America and Europe and in its 40 sales and support offices around the world. In its most recent fiscal year ended September 29, 2000, Varian Medical Systems reported sales of $690 million. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion